chr19-18086934-T-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000593993.7(IL12RB1):​c.-111A>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.209 in 1,547,552 control chromosomes in the GnomAD database, including 34,726 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3496 hom., cov: 31)
Exomes 𝑓: 0.21 ( 31230 hom. )

Consequence

IL12RB1
ENST00000593993.7 5_prime_UTR

Scores

2
Splicing: ADA: 0.00006553
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.34
Variant links:
Genes affected
IL12RB1 (HGNC:5971): (interleukin 12 receptor subunit beta 1) The protein encoded by this gene is a type I transmembrane protein that belongs to the hemopoietin receptor superfamily. This protein binds to interleukine 12 (IL12) with a low affinity, and is thought to be a part of IL12 receptor complex. This protein forms a disulfide-linked oligomer, which is required for its IL12 binding activity. The coexpression of this and IL12RB2 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. Mutations in this gene impair the development of interleukin-17-producing T lymphocytes and result in increased susceptibility to mycobacterial and Salmonella infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-18086934-T-A is Benign according to our data. Variant chr19-18086934-T-A is described in ClinVar as [Benign]. Clinvar id is 402972.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.243 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IL12RB1NM_005535.3 linkuse as main transcriptc.-111A>T 5_prime_UTR_variant 1/17 ENST00000593993.7 NP_005526.1 P42701-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IL12RB1ENST00000593993.7 linkuse as main transcriptc.-111A>T 5_prime_UTR_variant 1/171 NM_005535.3 ENSP00000472165.2 P42701-1

Frequencies

GnomAD3 genomes
AF:
0.212
AC:
32143
AN:
151432
Hom.:
3487
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.247
Gnomad AMI
AF:
0.138
Gnomad AMR
AF:
0.153
Gnomad ASJ
AF:
0.200
Gnomad EAS
AF:
0.154
Gnomad SAS
AF:
0.190
Gnomad FIN
AF:
0.229
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.207
GnomAD3 exomes
AF:
0.193
AC:
29266
AN:
151862
Hom.:
2923
AF XY:
0.195
AC XY:
15839
AN XY:
81364
show subpopulations
Gnomad AFR exome
AF:
0.248
Gnomad AMR exome
AF:
0.135
Gnomad ASJ exome
AF:
0.209
Gnomad EAS exome
AF:
0.134
Gnomad SAS exome
AF:
0.194
Gnomad FIN exome
AF:
0.221
Gnomad NFE exome
AF:
0.211
Gnomad OTH exome
AF:
0.178
GnomAD4 exome
AF:
0.209
AC:
291921
AN:
1396002
Hom.:
31230
Cov.:
32
AF XY:
0.209
AC XY:
143993
AN XY:
689156
show subpopulations
Gnomad4 AFR exome
AF:
0.247
Gnomad4 AMR exome
AF:
0.136
Gnomad4 ASJ exome
AF:
0.203
Gnomad4 EAS exome
AF:
0.193
Gnomad4 SAS exome
AF:
0.192
Gnomad4 FIN exome
AF:
0.217
Gnomad4 NFE exome
AF:
0.212
Gnomad4 OTH exome
AF:
0.204
GnomAD4 genome
AF:
0.212
AC:
32195
AN:
151550
Hom.:
3496
Cov.:
31
AF XY:
0.212
AC XY:
15731
AN XY:
74048
show subpopulations
Gnomad4 AFR
AF:
0.248
Gnomad4 AMR
AF:
0.152
Gnomad4 ASJ
AF:
0.200
Gnomad4 EAS
AF:
0.154
Gnomad4 SAS
AF:
0.191
Gnomad4 FIN
AF:
0.229
Gnomad4 NFE
AF:
0.210
Gnomad4 OTH
AF:
0.209
Alfa
AF:
0.215
Hom.:
680
Bravo
AF:
0.203
Asia WGS
AF:
0.195
AC:
681
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 32% of patients studied by a panel of primary immunodeficiencies. Number of patients: 28. Only high quality variants are reported. -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 19, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
5.5
DANN
Benign
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000066
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs393548; hg19: chr19-18197744; COSMIC: COSV59096451; COSMIC: COSV59096451; API